Worth a Shot? Evidence-Based Approach to Prescribing LAI Antipsychotic Medications-Presentation and Q&A

Video Transcription

Video Summary

The video is a recording of a webinar titled "Worth a Shot? Evidence-Based Approach to Prescribing LAI Antipsychotic Medications," hosted by SMI Advisor. The webinar is introduced by Donna Rowland, the Director of the Psychiatric Mental Health Nurse Practitioner Program at the University of Texas, Austin. SMI Advisor is an initiative by the American Psychiatric Association (APA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) to provide evidence-based care for those with serious mental illness.<br /><br />The webinar offers one AMA PRA Category 1 Credit for physicians and one Nursing Continuing Professional Development Pharmacology Hour. The presentation discusses the benefits of long-acting injectable (LAI) antipsychotic medications compared to oral formulations in patients with schizophrenia. It explores various studies and meta-analyses that have shown LAIs to be associated with lower risk of treatment failure, rehospitalization, drug discontinuation, violence, and mortality. It also highlights the advantages of LAIs, including convenience, decreased conflict with reminders, and reduced healthcare costs.<br /><br />The presenter, Dr. Leon Raven, a board-certified psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada, discusses the benefits of LAIs based on scientific, peer-reviewed evidence. The webinar concludes with a question and answer session. The video includes slides from the presentation, which are available for download in the handouts area of the webinar interface.<br /><br />Note: This summary is based on the provided transcript and does not include any additional comments or information from the speaker that may have been conveyed during the webinar.

Keywords

webinar

LAI antipsychotic medications

schizophrenia

studies

meta-analyses

convenience

healthcare costs

Dr. Leon Raven

question and answer session